Cost of Goods Sold (Quarterly)

Cost of Goods Sold: The difference between beginning and ending inventories for tangible products, resulting in an expense that reflects production and sales costs.

Phibro Animal Health Corporation (PAHC) had Cost of Goods Sold of $244.11M for the most recently reported fiscal quarter, ending 2025-09-30.

Quarterly Annual

Figures for fiscal quarter ending 2025-09-30

Income Statement Financials
Revenue	$363.89M
Net Income	$26.53M
Cost of Goods Sold	$244.11M
Gross Profit	$119.78M
Operating Expenses	$312.63M
Operating Income	$51.26M
Non-Operating Income/Expense	$-14.99M
Pre-Tax Income	$36.27M
Normalized Pre-Tax Income	$36.27M
Income after Taxes	$26.53M
Income from Continuous Operations	$26.53M
Consolidated Net Income/Loss	$26.53M
Normalized Income after Taxes	$26.53M
EBIT	$51.26M
EBITDA	$64.66M
Weighted-Average Shares Outstanding (Basic)	40.53M
Weighted-Average Shares Outstanding (Diluted)	40.88M
Earnings per Share (EPS) (Basic)	$0.65
Earnings per Share (EPS) (Diluted)	$0.65
Balance Sheet Financials
Current Assets	$835.80M
Property, Plant, and Equipment	$354.78M
Long-Term Assets	$549.73M
Total Assets	$1.39B
Current Liabilities	$270.14M
Long-Term Debt	$724.52M
Long-Term Liabilities	$803.70M
Total Liabilities	$1.07B
Common Equity	$311.68M
Tangible Shareholders Equity	$217.01M
Shareholders Equity	$311.68M
Common Shares Outstanding	40.56M
Cash Flow Statement Financials
Cash Flow from Operating Activities	$9.30M
Cash Flow from Investing Activities	$-21.01M
Cash Flow from Financial Activities	$16.34M
Beginning Cash	$68.04M
End Cash	$72.77M
Increase/Decrease in Cash	$4.73M
Stock-Based Compensation	$0.34M
Common Stock Dividends Paid	$-4.86M
Preferred Stock Dividends Paid	--
Fundamental Metrics & Ratios
Current Ratio	3.09
Non-Performing Assets / Total Loans	--
Loan Loss Reserves / Non-Performing Loans	--
Debt to Capital Ratio	0.70
Debt to Equity Ratio	2.38
Gross Margin	32.92%
Operating Margin	14.09%
EBIT Margin	14.09%
EBITDA Margin	--
Pre-Tax Profit Margin	9.97%
Profit Margin	7.29%
Free Cash Flow	$-4.50M
Loss Ratio	--
Expense Ratio	--
Combined Ratio	--
Asset Turnover	0.26
Inventory Turnover	0.52
Receiveable Turnover	1.67
Days Sales in Receivables	53.89
Return on Equity	8.51%
Return on Tangible Equity	12.22%
Return on Assets	1.91%
Return on Investments	2.56%
Book Value Per Share	$7.68
Free Cash Flow per Share	$-0.11
Operating Cash Flow per Share	$0.23

Data from Zacks Investment Research, Inc.